Study: New drug regimens improve outcomes for kidney transplant patients
IMAGE: BEST trial investigators E. Steve Woodle, M.D., and Rita Alloway, Pharm.D., both of the University of Cincinnati College of Medicine. view more CINCINNATI (June 5, 2019) — Preliminary results from a $5.2 million clinical trial led by University of Cincinnati researchers show that the immunosuppressive drug belatacept can help safely and effectively treat kidney transplant…